Parker Waichman LLP Aggressively Pursues Financial Compensation for Amputations Due to Diabetes Medication Dapagliflozin, better known by its brand name Farxiga, and a related medication Xigduo XR, is manufactured by the powerful pharmaceutical company AstraZeneca, and it is an SGT2 inhibitor diabetes drug. SGLT2 inhibitors, the class of diabetes drug called Gliflozins, can be […]
Dapagliflozin, better known by its brand name Farxiga, and a related medication Xigduo XR, is manufactured by the powerful pharmaceutical company AstraZeneca, and it is an SGT2 inhibitor diabetes drug. SGLT2 inhibitors, the class of diabetes drug called Gliflozins, can be dangerous to your health. Studies show a link between the Gliflozin class of drugs and amputation of the lower extremities. Additional studies prove that taking a Gliflozin-class drug like Farxiga or Xigduo XR can increase the potential for kidney damage and blood poisoning from ketoacidosis.
If you or someone you love was forced to have your toe, or toes, partial foot, foot, or any part of your leg amputated, or if you suffered an adverse medical effect from taking dapagliflozin, you could be eligible to receive financial compensation for those injuries. The dapagliflozin amputation attorneys from Parker Waichman LLP have vast experience representing injured people against large pharmaceutical companies like AstraZeneca. Parker Waichman’s products liability lawyers have tenacity, experience, and a documented track record of success you need on your side, fighting for you, in order to win the financial compensation you deserve for the loss of your limb. Parker Waichman’s dapagliflozin attorneys will also advocate for you so that you may also recover compensation for lost wages or earnings, as well as the pain and suffering you encountered from the loss of your leg or any other injuries you suffered from taking dapagliflozin.
Dapagliflozin is an SGLT2 inhibitor. People who have Type-2 diabetes mellitus are the only candidates for these medications. SGLT2 inhibitors are potent drugs designed to block the absorption of glucose in the blood, also known as blood sugar. SGLT2 is a protein that assists the kidneys to collect blood glucose and filter it back into the bloodstream. An SGLT2 inhibitor, such as Farxiga or Xigduo XR (XR meaning extended release), restricts nearly all of the glucose from returning to the blood. Instead, the kidneys filter the glucose out through the urine because the SGLT2 inhibitor keeps the glucose from being reabsorbed by the body.
AstraZeneca developed and marketed dapagliflozin under the brand names Farxiga and Xigudo XR. Xigduo XR is a combination of drugs. Xigduo XR contains the SGLT2 inhibitor dapagliflozin as well as metformin, which is another commonly used diabetes drug.
Dapagliflozin increases the level of acid in the blood and urine, which can lead to severe urinary tract infections. At first, a urinary tract infection might not seem all that serious. In fact, the opposite is true. Severe urinary tract infections, especially in the elderly, can lead to:
The condition becomes even more severe if the infection spreads to the kidneys. A kidney infection is not the only worry for diabetes patients. The U.S. Food and Drug Administration (FDA) issued a warning in May of 2016 that cautioned patients that dapagliflozin can cause severe kidney injuries. Specifically, the FDA warned that dapagliflozin could force the kidneys to shut down. The FDA counseled patients to seek immediate medical help if they stopped urinating or had pain and swelling in the legs and feet.
Ketoacidosis is a potentially fatal medical condition. Ketones are an acid that builds in your blood when the body stops using glucose for energy. Instead of insulin aiding the absorption of glucose into your muscles, the absence of insulin produces ketones, which in turn break down fat for fuel. The “Keto diet” is a very popular weight loss program based on that theory. However, in diabetics, the lack of insulin can quickly turn into ketoacidosis, a toxic condition for the body.
Diabetic ketoacidosis is a very serious condition. Doctors can treat it if quickly diagnosed. Ketoacidosis can cause confusion, vomiting, excessive thirst, and high blood sugar readings that approach dangerous levels. Ketoacidosis is possibly fatal if untreated. It is important to note that ketoacidosis can come on quickly and can occur within 24 hours. You should seek immediate medical attention if you are a diabetic and experience any symptoms of ketoacidosis.
AstraZeneca has the responsibility to warn its customers of the potential side effects of dapagliflozin. Furthermore, AstraZeneca must list those warnings on the medication label and inform the FDA when seeking approval to sell the drug. Failing to warn is the basis for legal action in many lawsuits involving injuries patients suffered when taking medication.
You must not delay in taking legal action if you or your loved one suffered an amputation or another injury from taking dapagliflozin. The statute of limitations, or deadline, to file your injury or products liability case could be as short as one year, depending on the state where you live or seek to file your claim. Waiting to file your claim could result in losing your claim forever.
The lawyers from Parker Waichman LLP have collected over $2 billion in damages for their personal injury clients. The dapagliflozin attorneys from Parker Waichman LLP possess the requisite skill, knowledge, and the resources needed to aggressively represent you in your pursuit of damages for your amputation, or complications due to infections or ketoacidosis.
Our lawyers are dedicated to superior advocacy, and we are proud to have received honors from the legal community and beyond, including:
Call Parker Waichman LLP today at 1-800-YOUR-LAWYER (1-800-968-7529) or go online and fill out our client contact form to get the high-quality representation you need for your dapagliflozin lawsuit.
